Closed-Loop Prevention of Hypotension in the Heartbeating Brain-Dead Porcine Model

 Objective: The purpose of this paper is to demonstrate feasibility of a novel closed-loop controlled therapy for prevention of hypertension in the heartbeating brain-dead porcine model. Methods: Dynamic modeling and system identification were based on in vivo data. A robust controller design was obtained for the identified models. Disturbance attenuation properties and reliability of operation of the resulting control system were evaluated in vivo. Results: The control system responded both predictably and consistently to external disturbances. It was possible to prevent mean arterial pressure to fall below a user-specified reference throughout 24 h of completely autonomous operation. Conclusion: Parameter variability in the identified models confirmed the benefit of closed-loop controlled administration of the proposed therapy. The evaluated robust controller was able to mitigate both process uncertainty and external disturbances. Significance: Prevention of hypertension is critical to the care of heartbeating brain-dead organ donors. Its automation would likely increase the fraction of organs suitable for transplantation from this patient group.

[1]  A. Sia,et al.  Closed‐loop double‐vasopressor automated system vs manual bolus vasopressor to treat hypotension during spinal anaesthesia for caesarean section: a randomised controlled trial , 2014, Anaesthesia.

[2]  Qiuming Liao,et al.  First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. , 2007, The Annals of thoracic surgery.

[3]  Andrea Gentilini,et al.  Closed-loop Control of Mean Arterial Blood Pressure during Surgery with Alfentanil: Clinical Evaluation of a Novel Model-based Predictive Controller , 2006, Anesthesiology.

[4]  Manfred Morari,et al.  A new paradigm for the closed-loop intraoperative administration of analgesics in humans , 2002, IEEE Transactions on Biomedical Engineering.

[5]  Thomas F. Edgar,et al.  Adaptive IMC control for drug infusion for biological systems , 2002 .

[6]  S. Steen,et al.  Pharmacological normalization of circulation after acute brain death , 2012, Acta anaesthesiologica Scandinavica.

[7]  Margarida Martins da Silva,et al.  Bifurcation analysis of PID-controlled neuromuscular blockade in closed-loop anesthesia , 2015 .

[8]  Kristian Soltesz,et al.  A synthesis method for automatic handling of inter-patient variability in closed-loop anesthesia , 2016, 2016 American Control Conference (ACC).

[9]  Clara M. Ionescu,et al.  Advanced Model-Based Control Studies for the Induction and Maintenance of Intravenous Anaesthesia , 2015, IEEE Transactions on Biomedical Engineering.

[10]  J S Packer,et al.  Clinical evaluation of closed‐loop control of blood pressure in seriously ill patients , 1991, Critical care medicine.

[11]  Torbjörn Wigren,et al.  Nonlinear Identification of a Minimal Neuromuscular Blockade Model in Anesthesia , 2012, IEEE Transactions on Control Systems Technology.

[12]  Lloyd H. Michael,et al.  The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.

[13]  J Schüttler,et al.  Population Pharmacokinetics of Propofol: A Multicenter Study , 2000, Anesthesiology.

[14]  J. Craig,et al.  Factors that influence the decision to be an organ donor: a systematic review of the qualitative literature. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  T. Kobayashi,et al.  The Pharmacokinetics of Insulin After Continuous Subcutaneous Infusion or Bolus Subcutaneous Injection in Diabetic Patients , 1983, Diabetes.

[16]  C. Schaefer-Prokop,et al.  Circulation stabilizing therapy and pulmonary high‐resolution computed tomography in a porcine brain‐dead model , 2016, Acta anaesthesiologica Scandinavica.

[17]  Guy A. Dumont,et al.  Closed-Loop Control of Anesthesia: A Primer for Anesthesiologists , 2013, Anesthesia and analgesia.

[18]  Stephen P. Boyd,et al.  Linear controller design: limits of performance , 1991 .

[19]  A. Hill,et al.  The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves , 1910 .

[20]  S. Steen,et al.  Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours , 2016, Scandinavian cardiovascular journal : SCJ.

[21]  Kristian Soltesz,et al.  Transfer function parameter identification by modified relay feedback , 2010, Proceedings of the 2010 American Control Conference.

[22]  M. Wilhelm,et al.  Brain death and its influence on donor organ quality and outcome after transplantation. , 1999, Transplantation.

[23]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[24]  Kristian Soltesz,et al.  Robust closed‐loop control of induction and maintenance of propofol anesthesia in children , 2013, Paediatric anaesthesia.

[25]  J. Kellum,et al.  Management of the heartbeating brain-dead organ donor. , 2012, British journal of anaesthesia.

[26]  A V Hill,et al.  The heat produced in contracture and muscular tone , 1910, The Journal of physiology.

[27]  J. A. Blom,et al.  Automated infusion of nitroglycerin to control arterial hypertension during cardiac surgery , 1996, Intensive Care Medicine.

[28]  B. Wayne Bequette,et al.  Challenges and recent progress in the development of a closed-loop artificial pancreas , 2012, Annu. Rev. Control..

[29]  Division on Earth Guide for the Care and Use of Laboratory Animals , 1996 .

[30]  R. Bonser,et al.  Endocrine changes in brain death and transplantation. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[31]  Tore Hägglund,et al.  Individualized closed-loop control of propofol anesthesia: A preliminary study , 2013, Biomed. Signal Process. Control..